Stay updated with breaking news from Enavate Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Since June, the Committee has subpoenaed documents from McKinsey, Curinos, BlackRock, Ernest & Young, and Goldman Sachs to unearth all available information.
OrsoBio has raised $60m in Series A financing to advance its metabolic portfolio for the treatment of obesity and associated disorders.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Biopharmaceutical company Immunome (IMNM) and private biotechnology company Morphimmune announced Thursday that they have entered into a definitive merger agreement to combine in an all-stock transaction.